Suraksha Diagnostic Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, through a regulatory filing under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board of Directors approved the results at their meeting held on February 05, 2026.

Standalone Financial Performance

The company demonstrated robust performance in Q3FY26 with significant year-over-year growth across key metrics.

Nine-Month Performance Highlights

For the nine months ended December 31, 2025, the company maintained strong momentum with consistent growth patterns.

Consolidated Results Overview

The consolidated financial results showed similar positive trends, reflecting the overall group performance including subsidiaries.

Operational and Financial Highlights

The company's cost structure remained well-managed with total expenses of ₹6,559.99 lakhs for Q3FY26 compared to ₹5,112.55 lakhs in the previous year. Employee benefits expenses stood at ₹1,303.31 lakhs, while depreciation and amortisation expense was ₹1,010.88 lakhs for the quarter.

Board Meeting and Compliance

The Board meeting commenced at 3:00 PM IST and concluded at 4:25 PM IST on February 05, 2026. The results were reviewed by MSKA & Associates LLP, the company's statutory auditors, who issued an unmodified review conclusion. The company operates primarily in diagnostic services for pathology and radiology, with no separate reportable segments under Ind AS 108.

The financial results are available on the company's website at www.surakshanet.com and on stock exchange websites. The company maintains its paid-up equity share capital at ₹1,041.62 lakhs with a face value of ₹2 per share.

Suraksha Diagnostic Limited has informed stock exchanges about a structural change in its statutory auditor's organization. The company's auditor, M S K A & Associates, has converted to a Limited Liability Partnership (LLP) structure effective January 13, 2026.

Auditor Conversion Details

The statutory auditor has transitioned from M S K A & Associates to M S K A & Associates LLP under the provisions of the Limited Liability Partnership Act, 2008. This conversion represents a change in the firm's legal structure while maintaining its core audit services.

Audit Continuity Maintained

Suraksha Diagnostic has confirmed that the conversion does not impact the continuity of the audit assignment or alter the scope of audit services. The company received formal notification from the auditor on January 16, 2026, regarding this structural change.

The auditor's communication emphasized that despite the name change and legal structure conversion, all existing audit arrangements remain intact. This ensures seamless continuation of statutory audit functions without any disruption to the company's compliance requirements.

Regulatory Compliance

The company has fulfilled its disclosure obligations by informing both BSE Limited and The National Stock Exchange of India Limited about this change. The notification includes the auditor's formal intimation letter as supporting documentation for regulatory records.

M S K A & Associates LLP operates from multiple locations across India, with its registered office in Mumbai and operational presence in cities including Kolkata, where the communication to Suraksha Diagnostic originated. The firm continues to provide chartered accountancy services under its new LLP structure while maintaining its established client relationships and service standards.